Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

SKU ID : QYR-17254123 | Publishing Date : 25-Jan-2021 | No. of pages : 133

Detailed TOC of Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Prostate Specific Antigen Test (PSA)
        1.2.3 Digital Rectal Exam (DRE)
    1.3 Market by Application
        1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Diagnostic clinics
        1.3.4 Research centers
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2016-2027)
    2.2 Prostate Cancer Diagnosis and Treatment Growth Trends by Regions
        2.2.1 Prostate Cancer Diagnosis and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Prostate Cancer Diagnosis and Treatment Industry Dynamic
        2.3.1 Prostate Cancer Diagnosis and Treatment Market Trends
        2.3.2 Prostate Cancer Diagnosis and Treatment Market Drivers
        2.3.3 Prostate Cancer Diagnosis and Treatment Market Challenges
        2.3.4 Prostate Cancer Diagnosis and Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue
        3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2016-2021)
        3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue
    3.4 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio
        3.4.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2020
    3.5 Prostate Cancer Diagnosis and Treatment Key Players Head office and Area Served
    3.6 Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
    3.7 Date of Enter into Prostate Cancer Diagnosis and Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnosis and Treatment Breakdown Data by Type
    4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2022-2027)

5 Prostate Cancer Diagnosis and Treatment Breakdown Data by Application
    5.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2016-2027)
    6.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Type
        6.2.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021)
        6.2.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027)
        6.2.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027)
    6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Application
        6.3.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021)
        6.3.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027)
        6.3.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027)
    6.4 North America Prostate Cancer Diagnosis and Treatment Market Size by Country
        6.4.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021)
        6.4.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.3 Canada

7 Europe
    7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2016-2027)
    7.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type
        7.2.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027)
    7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application
        7.3.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027)
    7.4 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country
        7.4.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type
        8.2.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application
        8.3.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region
        8.4.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size (2016-2027)
    9.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type
        9.2.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027)
    9.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application
        9.3.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027)
    9.4 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country
        9.4.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type
        10.2.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application
        10.3.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country
        10.4.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction
        11.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.1.5 Abbott Laboratories Recent Development
    11.2 AbbVie
        11.2.1 AbbVie Company Details
        11.2.2 AbbVie Business Overview
        11.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction
        11.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.2.5 AbbVie Recent Development
    11.3 Active Biotech
        11.3.1 Active Biotech Company Details
        11.3.2 Active Biotech Business Overview
        11.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction
        11.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.3.5 Active Biotech Recent Development
    11.4 Amgen
        11.4.1 Amgen Company Details
        11.4.2 Amgen Business Overview
        11.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction
        11.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.4.5 Amgen Recent Development
    11.5 Astellas Pharma
        11.5.1 Astellas Pharma Company Details
        11.5.2 Astellas Pharma Business Overview
        11.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction
        11.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.5.5 Astellas Pharma Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction
        11.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.6.5 AstraZeneca Recent Development
    11.7 Bavarian Nordic
        11.7.1 Bavarian Nordic Company Details
        11.7.2 Bavarian Nordic Business Overview
        11.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction
        11.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.7.5 Bavarian Nordic Recent Development
    11.8 Bayer
        11.8.1 Bayer Company Details
        11.8.2 Bayer Business Overview
        11.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction
        11.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.8.5 Bayer Recent Development
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Details
        11.9.2 Bristol-Myers Squibb Business Overview
        11.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction
        11.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.9.5 Bristol-Myers Squibb Recent Development
    11.10 Dendreon
        11.10.1 Dendreon Company Details
        11.10.2 Dendreon Business Overview
        11.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction
        11.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.10.5 Dendreon Recent Development
    11.11 Endo
        11.11.1 Endo Company Details
        11.11.2 Endo Business Overview
        11.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction
        11.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.11.5 Endo Recent Development
    11.12 Ferring Pharmaceuticals
        11.12.1 Ferring Pharmaceuticals Company Details
        11.12.2 Ferring Pharmaceuticals Business Overview
        11.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
        11.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.12.5 Ferring Pharmaceuticals Recent Development
    11.13 GE Healthcare
        11.13.1 GE Healthcare Company Details
        11.13.2 GE Healthcare Business Overview
        11.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction
        11.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.13.5 GE Healthcare Recent Development
    11.14 GSK
        11.14.1 GSK Company Details
        11.14.2 GSK Business Overview
        11.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction
        11.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.14.5 GSK Recent Development
    11.15 Ipsen
        11.15.1 Ipsen Company Details
        11.15.2 Ipsen Business Overview
        11.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction
        11.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.15.5 Ipsen Recent Development
    11.16 Johnson & Johnson
        11.16.1 Johnson & Johnson Company Details
        11.16.2 Johnson & Johnson Business Overview
        11.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction
        11.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.16.5 Johnson & Johnson Recent Development
    11.17 Pfizer
        11.17.1 Pfizer Company Details
        11.17.2 Pfizer Business Overview
        11.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction
        11.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.17.5 Pfizer Recent Development
    11.18 Sanofi
        11.18.1 Sanofi Company Details
        11.18.2 Sanofi Business Overview
        11.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction
        11.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.18.5 Sanofi Recent Development
    11.18 Siemens Healthineers
        .1 Siemens Healthineers Company Details
        .2 Siemens Healthineers Business Overview
        .3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction
        .4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        .5 Siemens Healthineers Recent Development
    11.20 Takeda
        11.20.1 Takeda Company Details
        11.20.2 Takeda Business Overview
        11.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction
        11.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.20.5 Takeda Recent Development
    11.21 Teva Pharmaceutical
        11.21.1 Teva Pharmaceutical Company Details
        11.21.2 Teva Pharmaceutical Business Overview
        11.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction
        11.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.21.5 Teva Pharmaceutical Recent Development
    11.22 Tolmar Pharmaceuticals
        11.22.1 Tolmar Pharmaceuticals Company Details
        11.22.2 Tolmar Pharmaceuticals Business Overview
        11.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
        11.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
        11.22.5 Tolmar Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

List of Tables
    Table 1. Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Prostate Specific Antigen Test (PSA)
    Table 3. Key Players of Digital Rectal Exam (DRE)
    Table 4. Global Prostate Cancer Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Prostate Cancer Diagnosis and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Prostate Cancer Diagnosis and Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2016-2021)
    Table 8. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2022-2027)
    Table 10. Prostate Cancer Diagnosis and Treatment Market Trends
    Table 11. Prostate Cancer Diagnosis and Treatment Market Drivers
    Table 12. Prostate Cancer Diagnosis and Treatment Market Challenges
    Table 13. Prostate Cancer Diagnosis and Treatment Market Restraints
    Table 14. Global Prostate Cancer Diagnosis and Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Prostate Cancer Diagnosis and Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2020)
    Table 17. Ranking of Global Top Prostate Cancer Diagnosis and Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
    Table 21. Date of Enter into Prostate Cancer Diagnosis and Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Abbott Laboratories Company Details
    Table 62. Abbott Laboratories Business Overview
    Table 63. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product
    Table 64. Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 65. Abbott Laboratories Recent Development
    Table 66. AbbVie Company Details
    Table 67. AbbVie Business Overview
    Table 68. AbbVie Prostate Cancer Diagnosis and Treatment Product
    Table 69. AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 70. AbbVie Recent Development
    Table 71. Active Biotech Company Details
    Table 72. Active Biotech Business Overview
    Table 73. Active Biotech Prostate Cancer Diagnosis and Treatment Product
    Table 74. Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 75. Active Biotech Recent Development
    Table 76. Amgen Company Details
    Table 77. Amgen Business Overview
    Table 78. Amgen Prostate Cancer Diagnosis and Treatment Product
    Table 79. Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 80. Amgen Recent Development
    Table 81. Astellas Pharma Company Details
    Table 82. Astellas Pharma Business Overview
    Table 83. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product
    Table 84. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 85. Astellas Pharma Recent Development
    Table 86. AstraZeneca Company Details
    Table 87. AstraZeneca Business Overview
    Table 88. AstraZeneca Prostate Cancer Diagnosis and Treatment Product
    Table 89. AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 90. AstraZeneca Recent Development
    Table 91. Bavarian Nordic Company Details
    Table 92. Bavarian Nordic Business Overview
    Table 93. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product
    Table 94. Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 95. Bavarian Nordic Recent Development
    Table 96. Bayer Company Details
    Table 97. Bayer Business Overview
    Table 98. Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 99. Bayer Recent Development
    Table 100. Bristol-Myers Squibb Company Details
    Table 101. Bristol-Myers Squibb Business Overview
    Table 102. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product
    Table 103. Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 104. Bristol-Myers Squibb Recent Development
    Table 105. Dendreon Company Details
    Table 106. Dendreon Business Overview
    Table 107. Dendreon Prostate Cancer Diagnosis and Treatment Product
    Table 108. Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 109. Dendreon Recent Development
    Table 110. Endo Company Details
    Table 111. Endo Business Overview
    Table 112. Endo Prostate Cancer Diagnosis and Treatment Product
    Table 113. Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 114. Endo Recent Development
    Table 115. Ferring Pharmaceuticals Company Details
    Table 116. Ferring Pharmaceuticals Business Overview
    Table 117. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product
    Table 118. Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 119. Ferring Pharmaceuticals Recent Development
    Table 120. GE Healthcare Company Details
    Table 121. GE Healthcare Business Overview
    Table 122. GE Healthcare Prostate Cancer Diagnosis and Treatment Product
    Table 123. GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 124. GE Healthcare Recent Development
    Table 125. GSK Company Details
    Table 126. GSK Business Overview
    Table 127. GSK Prostate Cancer Diagnosis and Treatment Product
    Table 128. GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 129. GSK Recent Development
    Table 130. Ipsen Company Details
    Table 131. Ipsen Business Overview
    Table 132. Ipsen Prostate Cancer Diagnosis and Treatment Product
    Table 133. Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 134. Ipsen Recent Development
    Table 135. Johnson & Johnson Company Details
    Table 136. Johnson & Johnson Business Overview
    Table 137. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product
    Table 138. Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 139. Johnson & Johnson Recent Development
    Table 140. Pfizer Company Details
    Table 141. Pfizer Business Overview
    Table 142. Pfizer Prostate Cancer Diagnosis and Treatment Product
    Table 143. Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 144. Pfizer Recent Development
    Table 145. Sanofi Company Details
    Table 146. Sanofi Business Overview
    Table 147. Sanofi Prostate Cancer Diagnosis and Treatment Product
    Table 148. Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 149. Sanofi Recent Development
    Table 150. Siemens Healthineers Company Details
    Table 151. Siemens Healthineers Business Overview
    Table 152. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product
    Table 153. Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 154. Siemens Healthineers Recent Development
    Table 155. Takeda Company Details
    Table 156. Takeda Business Overview
    Table 157. Takeda Prostate Cancer Diagnosis and Treatment Product
    Table 158. Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 159. Takeda Recent Development
    Table 160. Teva Pharmaceutical Company Details
    Table 161. Teva Pharmaceutical Business Overview
    Table 162. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product
    Table 163. Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 164. Teva Pharmaceutical Recent Development
    Table 165. Tolmar Pharmaceuticals Company Details
    Table 166. Tolmar Pharmaceuticals Business Overview
    Table 167. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product
    Table 168. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million)
    Table 169. Tolmar Pharmaceuticals Recent Development
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Diagnosis and Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Prostate Specific Antigen Test (PSA) Features
    Figure 3. Digital Rectal Exam (DRE) Features
    Figure 4. Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Diagnostic clinics Case Studies
    Figure 7. Research centers Case Studies
    Figure 8. Prostate Cancer Diagnosis and Treatment Report Years Considered
    Figure 9. Global Prostate Cancer Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Prostate Cancer Diagnosis and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Prostate Cancer Diagnosis and Treatment Market Share by Players in 2020
    Figure 14. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue in 2020
    Figure 16. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027)
    Figure 20. North America Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027)
    Figure 21. North America Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027)
    Figure 22. United States Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Region (2016-2027)
    Figure 38. China Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 58. AbbVie Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 59. Active Biotech Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 60. Amgen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 61. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 62. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 63. Bavarian Nordic Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 64. Bayer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 66. Dendreon Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 67. Endo Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 68. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 69. GE Healthcare Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 70. GSK Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 71. Ipsen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 72. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 73. Pfizer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 74. Sanofi Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 75. Siemens Healthineers Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 76. Takeda Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 77. Teva Pharmaceutical Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 78. Tolmar Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed

Keyplayers in Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

Abbott Laboratories
AbbVie
Active Biotech
Amgen
Astellas Pharma
AstraZeneca
Bavarian Nordic
Bayer
Bristol-Myers Squibb
Dendreon
Endo
Ferring Pharmaceuticals
GE Healthcare
GSK
Ipsen
Johnson & Johnson
Pfizer
Sanofi
Siemens Healthineers
Takeda
Teva Pharmaceutical
Tolmar Pharmaceuticals

Request Sample

Pre-order Enquiry

Request Discount

Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

Detailed TOC of Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

List of Figures, Tables and Charts Available in Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

Keyplayers in Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

Our Clients